CVS Health and UnitedHealth Group have asked FTC Chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices. The companies provided the motions to Reuters after filing them late on Tuesday with the FTC's in-house court. They said that Khan, Slaughter and Bedoya displayed bias against PBMs and prejudged their pricing models. CVS pointed to the commissioners' claims that volume-based discounts, or rebates, lead to higher prices for patients, and to Khan's appearance at a National Community Pharmacist Association event in 2022.
